Mark Allen

Managing Director at Orthoplastics Ltd

Mark Allen currently serves as the Managing Director at Orthoplastics Ltd, a position held since August 2014. Prior to this role, Mark Allen was the Technical Director at the same company. Mark Allen's career began as a Polymer Technologist at Rapra Technology Ltd, where tenure extended from 1988 to 1999.

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Orthoplastics Ltd

Work with a World leader in implantable plastic manufacturing and component machining. We will navigate you through the complexities of production, compliance and accreditation, getting your products to market quickly, saving you valuable time and money. Today, Orthoplastics is recognised globally as the leading supplier of UHMWPE, supplying many of the world’s orthopaedic device manufacturers. Its premium grade UHMWPE is expertly manufactured onsite in the UK and is the material of choice in a wide range of orthopaedic implants and devices for applications in hips, knees, shoulders, elbows, ankles and fingers. DEDICATED TO THE MEDICAL SECTOR Orthoplastics is fully dedicated to the medical sector, producing the highest grade of orthopaedic UHMWPE products on the market. A combination of rigorous quality control systems ensures that Orthoplastics continually exceed the Documented Quality System requirements of International Standards, including surpassing the specifications of 21 CFR 820. Orthoplastics have been accredited to ISO 9001, ISO 13485 and ISO 14001, which are all regulated under Validation Control (IQ, OQ/PQ) and FMEA studies. WORLD LEADER IN IMPLANTABLE PLASTICS MANUFACTURING Devoted to the medical industry, Orthoplastics is a world leader in the development and supply of both implantable-grade plastics and also biocompatible plastics for instrument applications. Orthoplastics has led the way in making recognisable contributions to the advancement of UHMWPE and its numerous applications. The superior consolidation and elevated purity achieved at Orthoplastics, in addition to the development of Vitamin E blended products, promises an extended product life span and a greatly improved quality of life for patients that receive orthopaedic implants.


Employees

51-200

Links